{{Rsnum
|rsid=12501123
|Gene=HPSE
|Chromosome=4
|position=83319501
|Orientation=plus
|GMAF=0.1915
|Gene_s=HPSE
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 59.3 | 37.2 | 3.5
| HCB | 81.0 | 16.8 | 2.2
| JPT | 68.1 | 28.3 | 3.5
| YRI | 81.0 | 17.7 | 1.4
| ASW | 84.2 | 15.8 | 0.0
| CHB | 81.0 | 16.8 | 2.2
| CHD | 79.8 | 19.3 | 0.9
| GIH | 71.3 | 24.8 | 4.0
| LWK | 69.1 | 29.1 | 1.8
| MEX | 51.7 | 41.4 | 6.9
| MKK | 64.1 | 30.8 | 5.1
| TSI | 57.8 | 39.2 | 2.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22952874
|Title=Allele Loss and Down-Regulation of Heparanase Gene Are Associated with the Progression and Poor Prognosis of Hepatocellular Carcinoma
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}